Amplified oncogenes and their involvement in cancer

Details for Australian Patent Application No. 2002326767 (hide)

Event Publications

23 January 2003 Complete Application Filed

Priority application(s): 60/340,863 19.12.01 US; 60/375,027 25.04.02 US; 60/314,655 27.08.01 US; 60/330,797 31.10.01 US

5 June 2003 Application Open to Public Inspection

Published as AU-A-2002326767

30 March 2006 Assignment before Grant

Tularik, Inc. The application has been assigned to Amgen Inc. Assignments before Grant, Section 113

1 May 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.